Tobramycin sulfate is an aminoglycoside antibiotic.It is effective against gram-negative bacteria, and especially potent against the Pseudomonas species.
This report contains market size and forecasts of Tobramycin Sulfate in global, including the following market information:
Global Tobramycin Sulfate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tobramycin Sulfate Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Tobramycin Sulfate companies in 2021 (%)
The global Tobramycin Sulfate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tobramycin Sulfate include Santa Cruz Biotechnology, AG Scientific, BioVision, LifeSpan BioSciences, Thermo Fisher Scientific, LGC, Adooq Bioscience, Boston BioProducts and Biorbyt, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tobramycin Sulfate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tobramycin Sulfate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Tobramycin Sulfate Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Tobramycin Sulfate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Tobramycin Sulfate Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Tobramycin Sulfate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Tobramycin Sulfate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tobramycin Sulfate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tobramycin Sulfate revenues share in global market, 2021 (%)
Key companies Tobramycin Sulfate sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Tobramycin Sulfate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Santa Cruz Biotechnology
AG Scientific
BioVision
LifeSpan BioSciences
Thermo Fisher Scientific
LGC
Adooq Bioscience
Boston BioProducts
Biorbyt
Clearsynth
Spectrum Chemical
Biosynth Carbosynth
LKT Laboratories